Drug Type Synthetic peptide |
Synonyms MET 06, MET06 |
Target |
Mechanism GLP-1R agonists(Glucagon-like peptide 1 receptor agonists) |
Therapeutic Areas |
Active Indication |
Inactive Indication- |
Originator Organization |
Active Organization |
Inactive Organization- |
Drug Highest PhaseDiscovery |
First Approval Date- |
Regulation- |
Indication | Highest Phase | Country/Location | Organization | Date |
---|---|---|---|---|
Obesity | Discovery | US | 18 Mar 2024 | |
Obesity | Discovery | KR | D&D Pharmatech Co., Ltd.Startup | 18 Mar 2024 |